Hospital
Indiana University Health White Memorial Hospital INC
Indiana University Health White Memorial Hospital INC was paid $5.20M by Medicaid between Jan 2018 and Nov 2024, across 47 billing codes. Its largest line is 99283, emergency room visit (moderate) — 51% of everything it billed.
33Billing provider infoINDIANA UNIVERSITY HEALTH WHITE MEMORIAL HOSPITAL INC
MONTICELLO, IN 47960
MONTICELLO, IN 47960
33aNPI1710983945assigned 06/22/2005
33bProvider typeCritical Access Hospital
28Total paid$5.20M
24GClaims69,923
24DCodes billed47
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Indiana
Rank by total paid#10 of 26
Median peer was paid$4.16M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,958 | $359K | |
| 2019 | 6,809 | $521K | |
| 2020 | 5,103 | $339K | |
| 2021 | 6,604 | $585K | |
| 2022 | 15,563 | $1.24M | |
| 2023 | 17,745 | $1.33M | |
| 2024incomplete | 9,141 | $825K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 51% | 14,740 | 13,640 | $2.65M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 5,431 | 4,866 | $911K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 4,544 | 3,860 | $601K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.1% | 2,021 | 1,861 | $162K |
| 71045 | Radiologic examination, chest; single view | 2.9% | 1,040 | 900 | $150K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.4% | 3,398 | 2,941 | $124K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.8% | 1,522 | 1,274 | $96K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.7% | 2,067 | 1,815 | $86K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 470 | 420 | $59K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 8,962 | 7,661 | $52K |
| 80053 | Comprehensive metabolic panel | <1% | 6,506 | 5,604 | $49K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,279 | 1,094 | $48K |
35 more codes
| 87503 | <1% | 1,787 | $44K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 912 | $34K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,343 | $27K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 81 | $18K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 474 | $14K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 358 | $11K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,164 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 507 | $7K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 59 | $6K |
| 84484 | <1% | 690 | $5K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 46 | $5K |
| 83735 | <1% | 666 | $4K | |
| 83690 | <1% | 725 | $4K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 54 | $3K |
| 81001 | <1% | 1,007 | $3K | |
| 83605 | <1% | 237 | $2K | |
| 83880 | <1% | 111 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 244 | $2K |
| 87276 | <1% | 167 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 83 | $2K |
| 81025 | <1% | 393 | $2K | |
| 87275 | <1% | 167 | $1K | |
| 81003 | <1% | 717 | $1K | |
| 85610 | <1% | 204 | $1K | |
| 85730 | <1% | 185 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 53 | $1K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 20 | $609.81 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 226 | $537.31 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 14 | $473.37 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 49 | $252.63 |
| 87807 | <1% | 19 | $238.00 | |
| 82550 | <1% | 68 | $198.54 | |
| 84100 | <1% | 87 | $195.36 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 14 | $134.40 |
| 85027 | <1% | 12 | $58.39 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMINIER, MARY (PRESIDENT)